September 26, 2016

Today's Top Alzheimer's News


A September 25, 2016 The Columbus Dispatch article reported that “An Ohio State University researcher is enrolling patients in the first U.S. clinical trials of two drugs being tested in the treatment of Lewy body dementia, one of the most common but least talked about neurodegenerative diseases.”

A September 25, 2016 article reported “a spinout from Stanford University, Inscopix, secured a $10M Series A funding round led by Playground Global in Palo Alto, California for its real-time brain mapping platform that gives scientists a tool to map brain function to neural circuits.” 

A September 23, 2016 The Fiscal Times opinion piece by Michael Hodin underscored the need to address Alzheimer’s globally. According to Hodin, “As we mark World Alzheimer’s Day 2016 this week, we’ve reached the point where Alzheimer’s demands greater attention. As with AIDS in the 1980s and 1990s, Alzheimer’s has become the subject of both legislation and movie scripts. It is starting to occupy that intersection of politics and art where, if history is any guide, change is born.”

A September 23, 2016 The New York Times article reported that “Terry Jones, an original member of Monty Python, has a form of dementia that is affecting his ability to communicate, his family said in a statement.”